Thomas C. Harding

Cell Genesys Inc.

关注

立即认领

关注

立即认领

基本信息

浏览量：125

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 190 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

BRCA1 Secondary Splice-Site Mutations Drive Exon-Skipping and PARP Inhibitor Resistance

Ksenija Nesic,John J. Krais,Yifan Wang,Cassandra J. Vandenberg,Pooja Patel,Kathy Q. Cai,Tanya Kwan,Elizabeth Lieschke,Gwo-Yaw Ho,Holly E. Barker,Justin Bedo,Silvia Casadei,Andrew Farrell,Marc Radke,Kristy Shield-Artin,Jocelyn S. Penington,Franziska Geissler, Elizabeth Kyran,Robert Betsch, Lijun Xu,Fan Zhang,Alexander Dobrovic,Inger Olesen,Rebecca Kristeleit,Amit Oza,Iain McNeish,Gayanie Ratnayake,Nadia Traficante,Anna DeFazio,David D. L. Bowtell,Thomas C. Harding,Kevin Lin,Elizabeth M. Swisher,Olga Kondrashova,Clare L. Scott,Neil Johnson,Matthew J. Wakefield

MOLECULAR CANCERno. 1 (2024)

引用3浏览0WOS引用

Table S2 from BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Kevin K. Lin,Maria I. Harrell,Amit M. Oza,Ana Oaknin, Isabelle Ray-Coquard,Anna V. Tinker,Elena Helman,Marc R. Radke, Carmen Say,Lan-Thanh Vo,Elaina Mann,Jeffrey D. Isaacson,Lara Maloney,David M. O'Malley,Setsuko K. Chambers,Scott H. Kaufmann,Clare L. Scott,Gottfried E. Konecny,Robert L. Coleman,James X. Sun,Heidi Giordano,James D. Brenton,Thomas C. Harding,Iain A. McNeish,Elizabeth M. Swisher

openalex（2023）

引用0浏览0引用

Supp Table 1 from Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Olga Kondrashova,Minh Nguyen,Kristy Shield-Artin,Anna V. Tinker,Nelson N.H. Teng,Maria I. Harrell,Michael J. Kuiper,Gwo-Yaw Ho,Holly Barker,Maria Jasin,Rohit Prakash,Elizabeth M. Kass,Meghan R. Sullivan,Gregory J. Brunette,Kara A. Bernstein,Robert L. Coleman,Anne Floquet,Michael Friedlander,Ganessan Kichenadasse,David M. O'Malley,Amit Oza,James Sun,Liliane Robillard,Lara Maloney,David Bowtell,Heidi Giordano,Matthew J. Wakefield,Scott H. Kaufmann,Andrew D. Simmons,Thomas C. Harding,Mitch Raponi,Iain A. McNeish,Elizabeth M. Swisher,Kevin K. Lin,Clare L. Scott

openalex（2023）

引用0浏览0引用

Supplementary Figure 6 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter,Robert Tjin Tham Sjin,Henry J. Haringsma,Kadoaki Ohashi,Jing Sun,Kwangho Lee,Aleksandr Dubrovskiy,Matthew Labenski,Zhendong Zhu,Zhigang Wang,Michael Sheets,Thia St Martin,Russell Karp,Dan van Kalken,Prasoon Chaturvedi,Deqiang Niu,Mariana Nacht,Russell C. Petter,William Westlin,Kevin Lin,Sarah Jaw-Tsai,Mitch Raponi,Terry Van Dyke,Jeff Etter,Zoe Weaver,William Pao,Juswinder Singh,Andrew D. Simmons,Thomas C. Harding,Andrew Allen

openalex（2023）

引用0浏览0引用

Supplementary Table 1 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

openalex（2023）

引用0浏览0引用

Supplementary Tables and Supplementary Figures 1 through 11 from Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

crossref（2023）

引用0浏览0引用

Supplementary Tables 1 Through 4 and Supplementary Figures 1 Through 5 from in Vitro and in Vivo Characterization of Irreversible Mutant-Selective EGFR Inhibitors That Are Wild-Type Sparing

Robert Tjin Tham Sjin,Kwangho Lee,Annette O. Walter,Aleksandr Dubrovskiy,Michael Sheets,Thia St. Martin,Matthew T. Labenski,Zhendong Zhu,Richland Tester,Russell Karp,Aravind Medikonda,Prasoon Chaturvedi, Yixuan Ren,Henry Haringsma,Jeff Etter,Mitch Raponi,Andrew D. Simmons,Thomas C. Harding,Deqiang Niu,Mariana Nacht,William F. Westlin,Russell C. Petter,Andrew Allen,Juswinder Singh

openalex（2023）

引用0浏览0引用

Supplementary Figure 5 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

openalex（2023）

引用0浏览0引用

Supplementary Figure 10 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

openalex（2023）

引用0浏览0引用

Supplementary Table 2 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

openalex（2023）

引用0浏览0引用

加载更多

作者统计

#Papers: 190

#Citation: 10201

H-Index: 39

G-Index: 100

Sociability: 7

Diversity: 3

Activity: 12

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn